Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

ESMO World Congress on Gastrointestinal Cancers 2023

28 Jun - 1 Jul 2023

Barcelona, Spain

Somatic and germline heterogeneity across colorectal cancer patient...

Prof Jeffrey Weitzel - The University of Kansas Cancer Center, Kansas, USA

Somatic and germline heterogeneity across colorectal cancer patient characteristics: Implications for early cancer detection ( Prof Jeffrey Weitzel - The University of Kansas Cancer Center, Kansas, USA )

Intra-arterial gemcitabine and IV gemcitabine/nab-paclitaxel show similar SAEs...

Dr Michael Pishvaian - Johns Hopkins Kimmel Cancer Center, Washington DC, USA

Intra-arterial gemcitabine and IV gemcitabine/nab-paclitaxel show similar SAEs in locally advanced pancreatic cancer ( Dr Michael Pishvaian - Johns Hopkins Kimmel Cancer Center, Washington DC, USA )

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal...

Dr Ronan Kelly - Baylor University Medical Center, Texas, USA

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis ( Dr Ronan Kelly - Baylor University Medical Center, Texas, USA )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

Lenvatinib plus pembrolizumab versus standard of care for previously treated...

Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer ( Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan )

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite...

Dr Andrea Bullock - Beth Israel Deaconess Medical Center, Boston, USA

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer ( Dr Andrea Bullock - Beth Israel Deaconess Medical Center, Boston, USA )

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Dr Michael White - MD Anderson Cancer Center, Houston, USA

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma ( Dr Michael White - MD Anderson Cancer Center, Houston, USA )

More from ecancer